Boron nitride nanofilms will replace antibiotics while protecting against bacterial and fungal infections according to scientists from NUST MISIS

TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

The first antiviral nasal spray in the United States. Nomovid™ Nasal Spray will be easy-to-use, low-cost and can be quickly made available over-the-counter for consumers.

Alterity has secured the worldwide exclusive right to patented technology to develop and commercialise therapies that re-sensitise bacteria to antibiotics